TGFB2 and hepatocellular carcinoma: TAN also releases TGF-β2 to stimulate microRNA-301-3p (miR-301-3p)-related stem cell features in oncogenic hepatocytes to increase angiogenesis in hepatocellular carcinoma (HCC) [94].